Interestingly, MEG3 was shown to downregulate TGFβ receptor 1 in fibroblasts by Mondal, which may appear discordant with our finding CAFs expressing MEG3 are associated with LNM-positive thyroid cancer since TGFβ signaling is needed for fibroblast activation. The gene discussed is MEG3; the disease is thyroid cancer.